Literature DB >> 30180144

CHANGES IN OPTICAL COHERENCE TOMOGRAPHY FINDINGS IN PATIENTS WITH CHRONIC RENAL FAILURE UNDERGOING DIALYSIS FOR THE FIRST TIME.

Hyeseong Hwang1, Ju Byung Chae1, Jin Young Kim2, Byung Gil Moon3, Dong Yoon Kim1.   

Abstract

PURPOSE: To investigate the spectral domain optical coherence tomography findings before and after dialysis in patients with diabetic end-stage renal disease undergoing dialysis for the first time.
METHODS: A retrospective medical review of patients with diabetic end-stage renal disease who recently started dialysis was conducted. Spectral domain optical coherence tomography findings before and after initiation of dialysis were analyzed. Systemic blood pressure, body weight, estimated glomerular filtration rate, and serum levels of blood urea nitrogen, creatinine (Cr), albumin, hemoglobin (Hb), and total CO2 were measured before and 1 month after starting dialysis. The correlations between the changes in these variables and the degree of decrease of the central subfield thickness after initiation of dialysis were analyzed.
RESULTS: A total 26 eyes from 15 patients were included. Among them, 14 started hemodialysis, and 1 started peritoneal dialysis. After initiation of dialysis, the incidence of any macular edema significantly decreased from 69.2% (18/26) to 26.9% (7/26) (P = 0.001). The central subfield thickness (317.92 ± 91.41 vs. 287.77 ± 57.55 μm, P = 0.006) and subfoveal choroidal thickness (313.31 ± 85.89 vs. 288.81 ± 92.02; P = 0.024) also significantly decreased. Improvement in blood urea nitrogen, Cr, Hb, and total CO2 levels in serum and estimated glomerular filtration rate was observed. A significant positive correlation between the amount of central subfield thickness decrease and the decrease in serum blood urea nitrogen was found (Pearson correlation coefficient: 0.481, P = 0.013).
CONCLUSION: Macular edema and central subfield thickness significantly decreased after initiation of dialysis in patients with diabetic chronic renal failure without any ocular treatment. This may be related to the improvement in uremia and volume overload after the initiation of dialysis.

Entities:  

Year:  2019        PMID: 30180144     DOI: 10.1097/IAE.0000000000002312

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  6 in total

1.  Analysis of risk factors for progressive fibrovascular proliferation in proliferative diabetic retinopathy.

Authors:  Yu-Bo Wu; Chen-Guang Wang; Ling-Xian Xu; Chen Chen; Xue-Bin Zhou; Guan-Fang Su
Journal:  Int Ophthalmol       Date:  2020-05-28       Impact factor: 2.031

2.  Relationship between diabetic macular edema and choroidal layer thickness.

Authors:  Hiroaki Endo; Satoru Kase; Mitsuo Takahashi; Michiyuki Saito; Masahiko Yokoi; Chisato Sugawara; Satoshi Katsuta; Susumu Ishida; Manabu Kase
Journal:  PLoS One       Date:  2020-01-07       Impact factor: 3.240

3.  Choroidal Thickness in Diabetes and Diabetic Retinopathy: A Swept Source OCT Study.

Authors:  Wei Wang; Sen Liu; Zhihan Qiu; Miao He; Lanhua Wang; Yuting Li; Wenyong Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-04-09       Impact factor: 4.799

4.  Incidence of Paradoxical Neurosensory Detachment in Diabetic Eyes Undergoing Hemodialysis for End-Stage Renal Disease.

Authors:  Kshitiz Kumar; Santosh Balasubramaniam; Pallavi Raj; Amar Agarwal
Journal:  Cureus       Date:  2021-04-28

5.  Relationship between Clinical Features of Diabetic Retinopathy and Systemic Factors in Patients with Newly Diagnosed Type II Diabetes Mellitus.

Authors:  Hyeseong Hwang; Jin Young Kim; Tae Keun Oh; Ju Byung Chae; Dong Yoon Kim
Journal:  J Korean Med Sci       Date:  2020-06-15       Impact factor: 2.153

6.  Visual/anatomical outcome of diabetic macular edema patients lost to follow-up for more than 1 year.

Authors:  Ji Soo Kim; Seungheon Lee; Jin Young Kim; Eoi Jong Seo; Ju Byung Chae; Dong Yoon Kim
Journal:  Sci Rep       Date:  2021-09-15       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.